Form4insider filings, from the source

SEC Form 4/A · accession 0001821353-26-000007

Whitehawk Therapeutics, Inc. · WHWK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
David Dornan
Officer — Chief Scientific Officer
Period of report
Sep 15, 2026
Accepted (ET)
Sep 18, 2026 · 4:43 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001422142

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F1$4.09Sep 15, 2026A85,887A—Sep 15, 2036Common Stock85,88785,887D
Restricted Stock UnitsF2,F3—Sep 15, 2026A85,887A——Common Stock85,88785,887D

Explanation of responses